Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial

Elena S George^{1

2}, Anjana Reddy², Amanda J Nicoll³, Marno C Ryan⁴, Catherine Itsiopoulos^{2

5}, Gavin Abbott¹, Nathan A Johnson⁶, Siddharth Sood⁷, Stuart K Roberts^{8

9}, Audrey C Tierney^{2

10}

Affiliations

¹ Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.
² School of Allied Health, Human Services and Sport, La Trobe University, Australia.
³ Department of Gastroenterology, Eastern Health, Box Hill, Australia.
⁴ Department of Gastroenterology and Hepatology, St Vincent's Hospital, Fitzroy, Australia.
⁵ School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.
⁶ The Boden Collaboration for Obesity, Nutrition, Exercise and Eating Disorders, The University of Sydney, Sydney, New South Wales, Australia.
⁷ Department of Gastroenterology, Melbourne Health, Melbourne, Australia.
⁸ Department of Gastroenterology, Alfred Health, Prahran, Australia.
⁹ Central Clinical School, Monash University, Clayton, Australia.
¹⁰ School of Allied Health, Health Implementation Science and Technology Centre, Health Research Institute, University of Limerick, Ireland.

PMID: 35357066
PMCID: PMC9544144
DOI: 10.1111/liv.15264

Randomized Controlled Trial

Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial

Elena S George et al. Liver Int. 2022 Jun.

. 2022 Jun;42(6):1308-1322.

doi: 10.1111/liv.15264. Epub 2022 Apr 26.

Authors

Affiliations

¹ Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.
² School of Allied Health, Human Services and Sport, La Trobe University, Australia.
³ Department of Gastroenterology, Eastern Health, Box Hill, Australia.
⁴ Department of Gastroenterology and Hepatology, St Vincent's Hospital, Fitzroy, Australia.
⁵ School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.
⁶ The Boden Collaboration for Obesity, Nutrition, Exercise and Eating Disorders, The University of Sydney, Sydney, New South Wales, Australia.
⁷ Department of Gastroenterology, Melbourne Health, Melbourne, Australia.
⁸ Department of Gastroenterology, Alfred Health, Prahran, Australia.
⁹ Central Clinical School, Monash University, Clayton, Australia.
¹⁰ School of Allied Health, Health Implementation Science and Technology Centre, Health Research Institute, University of Limerick, Ireland.

PMID: 35357066
PMCID: PMC9544144
DOI: 10.1111/liv.15264

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is predominantly managed by lifestyle intervention, in the absence of effective pharmacotherapies. Mediterranean diet (MedDiet) is the recommended diet, albeit with limited evidence.

Aims: To compare an ad libitum MedDiet to low-fat diet (LFD) in patients with NAFLD for reducing intrahepatic lipids (IHL) by proton magnetic resonance spectroscopy (¹ H-MRS). Secondary outcomes include insulin resistance by homeostatic model of assessment (HOMA-IR), visceral fat by bioelectrical impedance analysis (BIA), liver stiffness measurement (LSM) and other metabolic outcomes.

Methods: In this parallel multicentre RCT, subjects were randomised (1:1) to MedDiet or LFD for 12 weeks.

Results: Forty-two participants (25 females [60%], mean age 52.3 ± 12.6 years) were included, 23 randomised to LFD and 19 to MedDiet.; 39 completed the study. Following 12 weeks, there were no between-group differences. IHL improved significantly within the LFD group (-17% [log scale]; p = .02) but not within the MedDiet group (-8%, p = .069). HOMA-IR reduced in the LFD group (6.5 ± 5.6 to 5.5 ± 5.5, p < .01) but not in the MedDiet group (4.4 ± 3.2 to 3.9 ± 2.3, p = .07). No differences were found for LSM (MedDiet 7.8 ± 4.0 to 7.6 ± 5.2, p = .429; LFD 11.8 ± 14.3 to 10.8 ± 10.2 p = .99). Visceral fat reduced significantly in both groups; LFD (-76% [log scale], p = <.0005), MedDiet (-61%, p = <.0005).

Conclusions: There were no between-group differences for hepatic and metabolic outcomes when comparing MedDiet to LFD. LFD improved IHL and insulin resistance. Significant improvements in visceral fat were seen within both groups. This study highlights provision of dietary interventions in free-living adults with NAFLD is challenging.

Keywords: Mediterranean diet; dietary patterns; intrahepatic lipids; low-fat diet; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis.

PubMed Disclaimer

Conflict of interest statement

All authors have no perceived conflict of interest to declare.

Figures

**FIGURE 1**
MEDINA study inclusion and exclusion criteria

**FIGURE 2**
MEDINA participant flow chart

See this image and copyright information in PMC

References

1. Wah‐Kheong C, Khean‐Lee G. Epidemiology of a fast emerging disease in the Asia‐Pacific region: non‐alcoholic fatty liver disease. Hepatol Int. 2013;7(1):65‐71. - PubMed
1. Ratziu V, Bellentani S, Cortez‐Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53(2):372‐384. - PubMed
1. Lonardo A, Bellentani S, Argo CK, et al. Epidemiological modifiers of non‐alcoholic fatty liver disease: focus on high‐risk groups. Dig Liver Dis. 2015;47(12):997‐1006. - PubMed
1. Tarantino G, Conca P, Pasanisi F, et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol. 2009;21(5):504‐511. - PubMed
1. Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non‐alcoholic fatty liver disease. World J Gastroenterol. 2014;20(26):8341‐8350. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial

Affiliations

Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical